|
Physician.com promises to be the #1 destination for high tech physicians and discerning patients on the Internet today.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
From the Staff at Physician.com
|
|
|
Physician.com is now offering a "Money for Doctors" section on our website to help doctors find funding for their offices and services. We understand how difficult it can be to maintain a state of the art office for your patients and the high expense of purchasing new equipment that will help your patients live a more rewarding life.
Let Physician.com help you with funding your office and sleep better at night knowing that we can help you with your needs today.
|
|
Lyme-Like Illness To Be Studied In Texas
Tao Lin, D.V.M., and Steven J. Norris, Ph.D., both with the Department of Pathology and Laboratory Medicine at The University of Texas Medical School at Houston, have been named grant recipients of the Norman Hackerman Advanced Research Program (ARP) by the Texas Higher Education Coordinating Board.
FDA Approves First Generic Divalproex Sodium To Treat Seizures, Migraine Headaches And Bipolar Disorder
The U.S. Food and Drug Administration approved the first generic versions of Depakote delayed-release tablets (divalproex sodium). Depakote is approved by the FDA for the treatment of seizures, bipolar disorder and migraine headaches. "Generic drugs undergo a rigorous scientific review to ensure that they will provide the patient with the same amount of high quality, safe and effective drug as the name brand product," said Gary J.
Gene May Put Women With Migraine At Increased Risk Of Heart Disease And Stroke
Women who experience migraine with aura appear to be at an increased risk of heart disease and stroke if they have a certain gene, according to a study published in the July 30, 2008, online issue of Neurology®, the medical journal of the American Academy of Neurology. For the study, researchers followed 25,001 Caucasian women for the occurrence of cardiovascular disease, including heart attacks and ischemic stroke.
UPMC Conference To Discuss Newest Scientific Knowledge Forcing Doctors To Re-Think How To Safely Manage Concussions In Athletes Of All Levels
Treatment of concussions remains arguably the most complex and controversial issue in sports medicine for athletes of all ages, yet concussions occur in millions of athletes each year. The good news is that new scientific research continues to provide clearer knowledge for team doctors and athletic trainers, helping them to recognize and quantify the symptoms and effects of concussions.
News Tips From The Journal Of Neuroscience
1. Hodgkin CHuxley Model of Backpropagating Spikes Yuguo Yu, Yousheng Shu, and David A. McCormick Axon potentials recorded in somata of pyramidal neurons in vivo have a fast rising phase and variable threshold, contrary to predictions of the Hodgkin¨CHuxley model. Some have suggested that this difference is due to cooperativity among sodium channels, resulting in many channels opening simultaneously. Yu et al.
Oxygen Therapy Might Ease Pain Of Migraine, Cluster Headaches
Two types of oxygen therapy could offer some relief to adults who suffer from disabling migraine and cluster headaches, according to a new research review from Australia. Migraine headaches are severely painful and usually occur with other symptoms such as nausea, vomiting and painful sensitivity to light. Cluster headaches cause sharp, burning pain on one side of the head.
MAP Pharmaceuticals Initiates Phase 3 Clinical Trial In Patients With Migraine
MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) announced it has initiated its Phase 3 clinical program to evaluate MAP0004 as a potential treatment for migraine. MAP0004 is orally inhaled and self-administered at home using MAP Pharmaceuticals' proprietary Tempo(R) inhaler. In the company's prior Phase 2 efficacy study, MAP0004 provided pain relief in as fast as 10 minutes, with relief sustained through at least 24 hours.
FDA Panel Rejects Black Box Warning On Epilepsy Drugs
A panel of experts that advises the US Food and Drug Administration (FDA) voted last week to reject the Agency's proposal to make manufacturers of 11 epilepsy drugs put the strongest level of warning label on their products (the Black Box warning). The FDA had recommended the Black Box warning because studies showed the drugs had nearly double the risk of suicide compared to placebo, although in absolute terms it was still quite small.
Men And Women With History Of Concussion Mend Differently, Study Finds - Concussion Treatment Needs To Be More Individualized
Female soccer players and soccer players who have had a previous concussion recuperate differently from males or players without a history of concussion, new research released at the 2008 American Orthopaedic Society for Sports Medicine Annual Meeting at JW Marriott Orland Grande Lakes shows. The study found that prior history of concussion and gender account for significant differences in test results following the injury.
Combination Drug Taken Early Relieves Migraine Symptoms
A combination drug taken within an hour after the start of a migraine is effective in relieving symptoms, according to research published in the July 8, 2008, issue of Neurology®, the medical journal of the American Academy of Neurology.
NuPathe Reports Positive Phase I Results For NP101, A Novel Transdermal Patch For Acute Migraine
NuPathe Inc., a privately held specialty pharmaceutical company developing innovative products for the treatment of neurological and psychiatric diseases, announced positive Phase I results for NP101, a novel drug-device patch for acute migraine in clinical development.
Canadian Scientists Report On Pain Research At NIDCR's 60th Anniversary Symposium
Nearly everyone has experienced the acute, short-lived pain that occurs after a mild injury, but recent surveys reveal that more than 20% of the population has a chronic pain condition (i.e., pain that has lasted for 3 months or more) and for which treatment is often not very effective (e.g., low back pain, fibromyalgia, migraine headaches). Acute and chronic pain conditions have huge socio-economic costs.
Migraine Mutations Reveal Clues To Biological Basis Of Disorder
Fifteen percent to 20 percent of people worldwide suffer from migraines excruciating headaches often presaged by dramatic sensations, or "auras." By studying a rare, inherited form of migraine, researchers at Vanderbilt University Medical Center have found clues to the biological basis of the painful, debilitating disorder. In the Proceedings of the National Academy of Sciences, Alfred George Jr., M.D.
Zogenix Announces Clinical Study Results For Sumatriptan DosePro™, A Novel Migraine Treatment
Zogenix, Inc. ("Zogenix"), a private, specialty pharmaceutical company, announced that it will present successful results from two clinical studies of sumatriptan DosePro, a product in development for treatment of acute migraine and cluster headache, at the 50th Annual American Headache Society Meeting in Boston, Massachusetts.
Merck's Investigational Migraine Treatment Telcagepant Improved Pain And Migraine-Associated Symptoms In Phase III Study
Merck & Co., Inc. announced that, in a Phase III clinical trial, telcagepant (formerly MK-0974), its investigational oral calcitonin gene-related peptide (CGRP) receptor antagonist, significantly improved relief of migraine pain and migraine-associated symptoms two hours after dosing compared to placebo.
Data On Highly Effective Migraine Treatment Presented By OptiNose
OptiNose has announced that it presented important new data demonstrating the superior performance of its novel nasal drug delivery device with sumatriptan for the treatment of migraines. The Phase II results indicate that the drug-device combination achieves migraine relief as quickly and efficiently as injections without the discomfort, inconvenience and risk of needle-stick injuries. OptiNose presented the data at the Annual Scientific Meeting of the American Headache Society in Boston.
MAP Pharmaceuticals Reports Positive Pharmacological Response Data For Migraine Product Candidate At The American Headache Society Annual Meeting
MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) presented data from an in-vitro study evaluating receptor pharmacology of MAP0004, orally inhaled dihydroergotamine (DHE) for the potential treatment of migraine, compared to intravenous (IV) DHE. The study results were among six posters relating to the MAP0004 program that the Company presented at the American Headache Society 50th Annual Scientific Meeting in Boston, MA.
Migraine "Gun" Zaps Pain With The Touch Of Button - FDA Close To Approving Device That Uses Magnetic Bursts To Stop Pain
There are some 30 million Americans who suffer from migraine headaches.* Researchers at Ohio State University Medical Center have unveiled a new device that can control the pain of migraine headaches with no drugs, no injections, and no side effects. In fact this device is as easy as touching a button. After nearly eight years of development the migraine zapper could be on the market in a matter of months.
Knowledge And Understanding Ease Headache Frustrations
Headache frustrations are set to ease, thanks to a new range of patient leaflets. Produced by Lifting The Burden, the World Health Organization's Global Campaign to Reduce the Burden of Headache Worldwide, they will help sufferers understand and manage their headache more effectively. Almost all of us will have had a headache, but for many people it is more than just an irritant.
Medtronic Announces First Clinical Data On Occipital Nerve Stimulation For Chronic Migraine
Medtronic, Inc. (NYSE: MDT) announced that data from a multicenter, prospective, randomized, singleblinded, Controlled investigational study using its neurostimulation system to stimulate the occipital nerves as a potential approach to treating medically refractory chronic migraines will be presented during a late-breaking session at the annual scientific meeting of the American Headache Society (AHS) tomorrow in Boston.
Portable Device Effective In Zapping Away Migraine Pain
A novel electronic device designed to "zap" away migraine pain before it starts has proven to be the next form of relief for those suffering from the debilitating disease, according to a study conducted at The Ohio State University Medical Center. Results of the study, presented TODAY (6/27) at the annual American Headache Society meeting in Boston, found that the experimental device is safe and effective in eliminating headaches when administered during the onset of the migraine.
Headache Specialists Convene In Boston For 50th Annual American Headache Society Meeting
Headache specialists meet in Boston for the 50th annual meeting of the American Headache Society. Learn more about headache and face pain developments of the last 50 years -- including the top five advances in headaches -- and what researchers envision for the future.
Alexza Pharmaceuticals To Present AZ-104 Phase 2a Clinical Data At The American Headache Society Annual Scientific Meeting
Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced that it will present results of its Phase 2a clinical trial of Staccato(R) loxapine (AZ-104) for the treatment of migraine headache at the 50th Annual Scientific Meeting of the American Headache Society, which being held at the Marriott Boston Copley Place in Boston, MA.
Treating Chronic Pain, Migraine & Muscle Spasticity Through Inhibition Of Neurotransmitter Glutamate
A Webinar hosted by TorreyPines Therapeutics, Inc. (NASDAQ: TPTX) at 11 a.m. EDT on June 25 will bring together industry experts to discuss the opportunity of treating chronic pain, migraine and muscle spasticity through the inhibition of the neurotransmitter glutamate. The company's President and Chief Executive Officer, Neil Kurtz, M.D., will moderate a discussion following brief presentations by: Tony Yaksh, Ph.D.
Shower Curtains Can Be Toxic Says Environment Group
A US health and environment group is calling for major retailers such as Wal-Mart to phase out PVC shower curtains, and for the authorities to recall the products from sale because a laboratory study showed they released toxic chemicals into the air.
|
|
|
 |
|
New York Times Examines New Ovarian Cancer Test
The clinical laboratory company LabCorp is offering a new blood test aimed at detecting ovarian cancer at an early and still treatable stage, but the test is being met with concern among many physicians and medical organizations, the New York Times reports.
Molecular Diagnostics In Cancer Therapeutic Development Meeting Hosted By AACR
Premier international meeting highlights breakthroughs in molecular cancer diagnostics research What: The AACR Molecular Diagnostics in Cancer Therapeutics Development Meeting features the latest findings in laboratory, translational and clinical cancer research. This year's meeting focuses on new biologic markers and imaging methods.
Endoscopic Ultrasound Highly Accurate In Evaluating Ambiguous Radiographic Findings Of The Pancreas
Researchers from St. Louis University School of Medicine in Missouri report that EUS and EUS-FNA is 99.1 percent accurate in diagnosing pancreatic neoplasms (abnormal growths or tumors) in patients who were referred for endoscopic ultrasound (EUS) because of CT and/or MRI reports of two common, though somewhat ambiguous findings - enlargement of head of pancreas (HOP) or dilation of the pancreatic duct (PD).
University Of Oklahoma Researchers Developing New Tool To Detect Cancer
Early cancer detection can significantly improve survival rates. Current diagnostic tests often fail to detect cancer in the earliest stages and at the same time expose a patient to the harmful effects of radiation. Led by Dr. Patrick McCann, a small group of internationally known researchers at the University of Oklahoma with expertise in the development of mid-infrared lasers is working to create a sensor to detect biomarker gases exhaled in the breath of a person with cancer.
News From The Journal Of The National Cancer Institute, August 26 2008
Novel Trial Design Aims to Speed Drug Development Researchers propose a novel multi-arm trial design that can test several therapies simultaneously and could speed drug development in cancer. Scientists have gained important insights into the biological underpinnings of cancer, but this knowledge has not led to a jump in the number of therapies approved for clinical use.
Link Between Angiotensin Inhibitors, Receptor Blockers And Lower Risk Of Nonmelanoma Skin Cancer
The use of angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) was associated with a reduced risk of basal cell or squamous cell skin cancers in U.S. veterans, researchers report in the August 26 online issue of the Journal of the National Cancer Institute. ACE inhibitors and ARBs are frequently prescribed medications for the treatment of high blood pressure.
Greater Risk Of Cancers Associated With History Of Nonmelanoma Skin Cancer
Individuals with a history of nonmelanoma skin cancer (NMSC) are at increased risk for other cancers, according to a study published in the August 26 online issue of the Journal of the National Cancer Institute. Previous studies have documented that people who have had nonmelanoma skin cancer were at increased risk for developing melanoma, but it is less well-established whether they were also at risk for cancers that do not involve the skin.
New Role For Natural Killers!
Scientists at the University of York have discovered a new role for a population of white blood cells, which may lead to improved treatments for chronic infections and cancer. Natural Killer (or NK) cells are abundant white blood cells that were recognised over 30 years ago as being able to kill cancer cells in the test tube.
2008 Breast Cancer Symposium Awards $14,000 To Oncology Fellows
Organizers of the 2008 Breast Cancer Symposium announced the winners of the Symposium Merit Awards. Fourteen physicians-in-training will receive funding to assist with their travel to attend the Symposium, to be held September 5-7 in Washington, DC.
Third Conference In The Molecular Diagnostics Series
Molecular Diagnostics in Cancer Therapeutic Development: Fulfilling the Promise of Personalized Medicine. September 22 - 25, 2008, Marriott Philadelphia Downtown Philadelphia, PA Please join us this September as AACR's home city of Philadelphia hosts the third conference in the Molecular Diagnostics series.
Three Leading European Comprehensive Cancer Centres Launch An International Cooperation At Top Level
Three European cancer centres in Paris (Institut Gustave Roussy), Amsterdam (Netherlands Cancer Institute) and in Stockholm (Karolinska Institutet), have joined forces in their battle against cancer. In a collaborative effort, the European Comprehensive Cancer Centre Alliance (ECCCA) strives to develop and implement innovative strategies to improve cancer cure and reduce treatment related side effects.
Individuals With History Of Nonmelanoma Skin Cancer At Greater Risk For Future Cancers
Individuals with a history of nonmelanoma skin cancer (NMSC), especially those who had it at a younger age, are at significantly greater risk for future cancers, according to a study led by Anthony J. Alberg, Ph.D., of the Hollings Cancer Center at the Medical University of South Carolina. The study, which followed more than 19,000 people for 16 years, will be published August 26 in the Journal of the National Cancer Institute.
New Journals: Case Reports In Gastroenterology And Case Reports In Oncology
Karger Publishers is pleased to announce two new online journals dedicated exclusively to case reports: Case Reports in Gastroenterology and Case Reports in Oncology. These peer-reviewed online-only journals are two new forums devoted to publishing case reports. They cover the entire spectrum of their specific fields of medicine, including prevention, diagnosis, treatment, toxicities of therapy, supportive care, quality-of-life and survivorship issues.
Singer Sandi Thom Ages 30 Years To Warn Young People About Sunbeds
Singer/songwriter Sandi Thom, aged 27, has teamed up with Cancer Research UK to warn youngsters about the dangers of using sunbeds. The charity has today published shocking images of how Sandi could look in thirty years time through overexposure to UV rays, which in some sunbeds can be 10-15 times higher than those of the midday sun.
Cancer Patients Are Kept In The Dark Surrounding Treatments Awaiting NICE Approval, UK
One in four doctors choose not to discuss life extending cancer treatments that are awaiting NICE (National Institute for Health and Clinical Excellence) approval with their patients. The research, commissioned by Myeloma UK, also revealed that 75 percent of doctors receive no guidance on discussing the availability of these treatments with their patients and a fifth of doctors believe that prescribing new treatment options for myeloma is completely 'out of their hands'.
Robotic Kidney Removal Performed In Michigan
A diseased kidney has been surgically extracted using a minimally invasive technique that utilizes 3D robotics, at the Henry Ford Hospital, the first surgery of its kind in Michigan. About 55,000 people are diagnosed with kidney cancer every year. Treatment options, most commonly, involve open surgery with an incision approximately one foot (300 mm) long. Sometimes it is necessary to remove a rib and divert muscle in order to remove the kidney.
New Target For Fight Against Common Type Of Breast Cancer: Brk
A new promising enzyme target for a specific type of breast cancer, Brk, has been identified in research published on August 21, 2008 in the Proceedings of the National Academy of Sciences (PNAS.) In a specific subset of breast cancer patients, the tumor cells produce high levels of the protein ErbB2 (also called HER2) which pushes the cells to proliferate without limit, a characteristic common of all cancers.
Flower Power: Tel Aviv University Researchers Are Combatting Cancer With A Jasmine-Based Drug
Could a substance from the jasmine flower hold the key to an effective new therapy to treat cancer? Prof. Eliezer Flescher of The Sackler Faculty of Medicine, Tel Aviv University thinks so. He and his colleagues have developed an anti-cancer drug based on a decade of research into the commercial applications of the compound Jasmonate, a synthetic compound derived from the flower itself. Prof.
Gene Found For Rare And Deadly Chidhood Cancer Neuroblastoma
US scientists have found that mutations of a gene called anaplastic lymphoma kinase (ALK) were behind most incidences of hereditary neuroblastoma, a rare and deadly childhood cancer, and they also discovered that the same mutations played an important role in high risk forms of non-inherited incidences of the disease, which are more common.
Viral Cancers - Sylvester Researcher Discovers Key Molecule That Triggers Immune Response
Scientists have long been working to uncover the mystery of what sparks the body's immune system. Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have discovered a key component in that puzzle: a new molecule that recognizes a virus infection and initiates the signal to generate an immune system response. Glen N. Barber, Ph.D., professor of medicine and Eugenia J. Dodson Chair in Cancer Research, and Hiroki Ishikawa, Ph.D.
American Medical Student Association Academy Provides Leadership Training For Tomorrow's Physicians
The American Medical Student Association (AMSA), the nation's oldest and largest, independent association for physicians-in-training, announces the commencement of AMSA Academy, a training ground for physician leaders. Established by students, for students, AMSA Academy takes medical students through the core competencies of leadership and project implementation, while building on key principles of important topics in medicine. There are currently 22 programs offered.
Radiation Oncology Institute Launched, Receives $5 Million Grant
To prepare the specialty of radiation oncology for the future, the American Society for Therapeutic Radiology and Oncology has donated $5 million to formally launch the Radiation Oncology Institute. Also called by its acronym, ROI, the mission of this new organization is to enhance and promote the critical role of the radiation oncologist in the world cancer community by supporting research and education on the life-saving and quality-of-life benefits of radiation therapy.
Asian-American/Pacific Islanders Have Higher Survival Rates Than Others For Gastric Cancers, Study Finds
Asian-American/Pacific Islanders with early-stage stomach cancers have an overall median survival rate that is higher than those of other races or ethnicities, according to new research, Reuters Health reports.For the study, Barry Feig of the University of Texas M.D.
Genmab Has Announced Plans To Begin Four Studies Of Ofatumumab In Chronic Lymphocytic Leukemia And Non-Hodgkin's Lymphoma
Genmab A/S (OMX: GEN) announced plans to begin four studies of ofatumumab in chronic lymphocytic leukemia (CLL) and follicular non-Hodgkin's lymphoma (NHL) this year. "Genmab and GSK have worked diligently to expand the ofatumumab development program to maximize the value of the antibody for patients and shareholders since our collaboration began," said Lisa N. Drakeman, Ph.D., Chief Executive Officer of Genmab.
Global Survey Highlights Need For Cancer Prevention Campaigns To Correct Misbeliefs
Many people hold mistaken beliefs about what causes cancer, tending to inflate the threat from environmental factors that have relatively little impact while minimizing the hazards of behaviours well established as cancer risk factors, according to the first global survey on the topic.
|
|
|
|
International Diabetes Federation Supports Study To Foster Improved Control Of Type 2 Diabetes
The International Diabetes Federation (IDF) BRIDGES translational research grant program will fund a diabetes self-management education study in Dallas. Self-management education is an important component in diabetes care and designed to help people with diabetes to gain and maintain control of their condition.
Type-2 Young Diabetic Men Suffer Low Testosterone Levels Which Affects Fertility, Muscle Mass, Heart Health
Young men with type 2 diabetes have significantly low levels of testosterone, endocrinologists at the University at Buffalo have found - a condition that could have a critical effect on their quality of life and on their ability to father children. This study follows research published earlier by these scientists reporting that one-third of middle-aged men with type 2 diabetes have low testosterone levels, requiring treatment for erectile dysfunction.
Mouse Study Uncovers Early Trigger For Type-1 Diabetes
Scientists at the Stanford University School of Medicine are shedding light on how type-1 diabetes begins. Doctors have known the disease is caused by an autoimmune attack on the pancreas, but the exact trigger of the attack has been unclear. Now, a new study in mice implicates the immune signal interferon-alpha as an early culprit in a chain of events that upend sugar metabolism and make patients dependent on lifelong insulin injections.
Scientists Change Living Pancreatic Cells Into Insulin Producers
US scientists have discovered a way to transform living pancreatic cells in mice into another type of cell that produces insulin without having to revert to the stem cell stage, creating what is now a third route for cell reprogramming to add to the existing methods of iPS (induced pluripotent stem cells) and hES (human embryonic stem cells).
Caesarean Babies More Likely To Develop Diabetes
Babies delivered by Caesarean section have a 20 per cent higher risk than normal deliveries of developing the most common type of diabetes in childhood, according to a study led by Queen's University Belfast. The team, led by Dr Chris Cardwell and Dr Chris Patterson, examined 20 published studies from 16 countries including around 10,000 children with Type 1 diabetes and over a million control children.
Should Tight Glucose Control For The Critically Ill Be Reconsidered?
New findings published in the August 27 issue of JAMA call into question the tight glucose control that many professional societies recommend for critically ill adults. Researchers performed a meta-analysis and found that tight glucose control is not associated with a significant reduction in risk of death in the hospital, but it is linked to an increased risk of hypoglycemia (lower than normal glucose sugar levels).
Home Diagnostics Receives FDA Clearance For TRUE2go, TRUEresult No-Coding Blood Glucose Monitoring Systems
Home Diagnostics, Inc. (NASDAQ:HDIX), a leading manufacturer and marketer of diabetes testing supplies, announced today that it received 510(k) clearance from the U.S. Food and Drug Administration for the world's smallest blood glucose meter, TRUE2go™, and for TRUEresult™, the company's latest advanced performance, no-coding meter for at-home testing.
Scientists Discover Leptin Can Also Aid Type 1 Diabetics
Terminally ill rodents with type 1 diabetes have been restored to full health with a single injection of a substance other than insulin by scientists at UT Southwestern Medical Center. Since the discovery of insulin in 1922, type 1 diabetes (insulin-dependent diabetes) in humans has been treated by injecting insulin to lower high blood sugar levels and prevent diabetic coma.
Endocrinologists And Surgeons Join Forces To Fight Type 2 Diabetes
At the 1st World Congress for Interventional Therapies for Type 2 Diabetes, prominent endocrinologists from around the world will convene in an exchange with leading surgeons about the role of surgery and other emerging new therapies for type 2 diabetes.
Low Cholesterol Associated With Cancer In Diabetics
Low levels of LDL cholesterol as well as high levels are associated with cancer in patients with type 2 diabetes, found a prospective cohort study published in CMAJ.
Prevention Needed To Trim The Fat, Australian Medical Association
Australian Medical Association President, Dr Rosanna Capolingua, said that findings in a new report show the obesity epidemic is costing the nation $58 billion a year and confirms that many Australians are suffering significant health problems due to obesity. "This reflects the dollar cost to Australians and the human cost to individuals," she said.
New Books Suggests 'Nutraceuticals' Could Prevent Diabetes
People at high risk for developing type 2 diabetes might be able to delay or prevent the disease by taking certain food supplements and making lifestyle changes, according to a new book by Dr. James W. Anderson, an internationally recognized authority on metabolic diseases and weight loss and professor emeritus of medicine and clinical nutrition at the University of Kentucky College of Medicine. Diabetes is a worldwide epidemic, and it is growing at an alarming rate.
Australia's Wake-Up Call - Obesity Costs Now At $58 Billion Type 2 Diabetes Crisis
A new Access Economics Report commissioned by Diabetes Australia has found that 3.71 million Australians are obese with a current estimated cost to the nation of $58 billion. The report titled "Growing economic costs of obesity in 2008" reveals that there has been a 137% increase since 2005 in the number of Australians who have type 2 diabetes as a result of being obese. The total cost of obesity includes $8.3 billion in financial costs and $49.
Obesity In Later Life Leads To Increased Risks Of Disability But Not Of Dying - And To 'a Ticking Time Bomb' For Health And Social Services
Research carried out at the Peninsula Medical School in the South West of England has discovered that obesity in later life does not make a substantial difference to risks of death among older people but that it is a major contributor to increased disability in later life - creating a ticking time bomb for health services in developed countries. The research is published in the August 2008 edition of the Journal of the American Geriatrics Society.
Caesarean Babies More Likely To Have Type 1 Diabetes
New research¹ reveals that mothers giving birth by Caesarean section have a 20 per cent higher risk of their baby developing Type 1 diabetes in childhood compared to those having natural births, warns leading health charity Diabetes UK. The research examined 20 published studies on children with Type 1 diabetes born by Caesarean section and found that there was a 20 per cent increase in the risk of babies born by Caesarean section developing Type 1 diabetes.
Swedish Diabetics Experience Decline In Stroke Incidence
The incidence of strokes among diabetics in Northern Sweden declined between 1985 and 2003, according to a population-based study published in Stroke: Journal of the American Heart Association. Researchers also found that survival rates improved leading to a rapid decline in the number of fatal events among diabetic people.
Australian Disease Research Boosted By National Alliance
Nine of the nation's leading scientific research institutions have launched a new partnership to boost Australia's research capacity for tackling major health problems including cancer, diabetes, deafness, infertility, autoimmune disease and arthritis. The Australian Phenomics Network (APN) is providing Australian and International researchers with the latest infrastructure for the study of human disease.
Texas' Rio Grande Valley Region Has High Diabetes Rate; Large Hispanic Population Considered Contributing Factor
The Rio Grande Valley region in Texas has a diabetes rate of about three times the national rate, officials said on Monday at an event in McAllen, Texas, the McAllen Monitor reports. The event was sponsored by the American Diabetes Association.
Identification Of Protein That Produces 'Good' Fat, Has Potential To Treat, Prevent Obesity
A study by researchers at the Joslin Diabetes Center has shown that a protein known for its role in inducing bone growth can also help promote the development of brown fat, a "good" fat that helps in the expenditure of energy and plays a role in fighting obesity. "Obesity is occurring at epidemic rates in the U.S. and worldwide and that impacts the risk and prognosis of many diseases," said Yu-Hua Tseng, Ph.D.
An Unusual Form Of Inheritance May Have A Role In The Rising Rate Of Diabetes
A new study in the September issue of the Journal of Lipid Research suggests an unusual form of inheritance may have a role in the rising rate of diabetes, especially in children and young adults, in the United States. DNA is the primary mechanism of inheritance; kids get half their genes from mom and half from dad.
Government report glosses over diabetes care failings, UK
A government report released 'Five Years On - Delivering the Diabetes National Service Framework' has analysed progress of the government's 10-year diabetes plan, published in 2003. "The NHS has responded impressively to the first five years of the national service framework [the government diabetes plan]. More and more people with diabetes are getting good routine care," said National Clinical Director for Diabetes, Dr Rowan Hillson MBE.
New Research On Sexual Function
Young researchers presented innovative, early-stage research at the 16th Annual Summer Research Conference, a collaborative project of the AUA Foundation and the Society for Basic Urologic Research (SBUR). The AUA Foundation hosted the forum for young investigators to showcase and discuss the most cutting-edge research in sexual medicine.
Education For Young People With Diabetes Evaluated
New research commissioned by the National Institute for Health Research's Health Technology Assessment (NIHR HTA) programme is set to investigate the effectiveness and cost-effectiveness of a structured educational programme for helping young people to manage their diabetes. The incidence of type 1 diabetes in children continues to rise and 1 in 700 children are now affected.
Progress Made In NHS Diabetes Care, UK
Diabetes care in the NHS is improving and focussing more o prevention, according to a report published by the Department of Health.
New Data Show Duloxetine Maintained Pain Reduction For More Than Six Months In Patients With Diabetic Peripheral Neuropathic Pain
Duloxetine hydrochloride maintained pain reduction in the treatment of diabetic peripheral neuropathic pain (DPNP) for more than six months,[i] according to new data presented today at the 12th World Congress on Pain in Glasgow, Scotland. The open-label study, which aimed to evaluate long-term maintenance of effect of duloxetine 60 mg once daily, is the first to assess the efficacy of duloxetine in DPNP beyond three months.
|
|
|
|
|